8-KThe DealStrategic
Acquisition / Disposition · Reg FD Disclosure
Filed Sep 12, 2025 · 9mo ago · Accession 0001437749-25-028949
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- NRX Pharmaceuticals, Inc.
- Ticker
- NRXP
- CIK
- 1719406
- Form type
- 8-K
- Filing date
- Sep 12, 2025
- Report date
- Sep 8, 2025
- Document
- nrxp20250912_8k.htm
- Size
- 237 KB